• Sarepta Therapeutics (NASDAQ:SRPT) Earns "Buy" Rating from Needham & Company LLC

    المصدر: Buzz FX / 14 يناير 2025 08:36:16   America/New_York


    Sarepta Therapeutics (NASDAQ:SRPT) Earns "Buy" Rating from Needham & Company LLC Written by MarketBeat January 14, 2025 Share Link copied to clipboard. Sarepta Therapeutics ( NASDAQ:SRPT - Get Free Report ) 's stock had its "buy" rating rei
    Read more...
شارك على،